326 filings
ARS
2023 FY
VCYT
Veracyte Inc
25 Apr 24
Annual report to shareholders
4:38pm
DEFA14A
VCYT
Veracyte Inc
25 Apr 24
Additional proxy soliciting materials
4:36pm
DEF 14A
VCYT
Veracyte Inc
Definitive proxy
25 Apr 24
4:34pm
8-K/A
VCYT
Veracyte Inc
17 Apr 24
Consolidated Financial Statements
4:34pm
8-K
VCYT
Veracyte Inc
22 Mar 24
Other Events
4:49pm
424B7
vkek5680rl
22 Mar 24
Prospectus with selling stockholder info
4:47pm
8-K
s0lpokxll
29 Feb 24
Other Events
5:27pm
424B7
2tikmmhe8bdq wn14r
29 Feb 24
Prospectus with selling stockholder info
5:22pm
S-8
9w0qd477ft qvuh84
29 Feb 24
Registration of securities for employees
5:20pm
S-3ASR
1anwzp
29 Feb 24
Automatic shelf registration
4:40pm
8-K
24au1w
22 Feb 24
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
4:12pm
8-K
5gz6tbu5zxxnx1hk
13 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
ns6rco1s
6 Feb 24
Completion of Acquisition or Disposition of Assets
8:23am
8-K
1awpp
8 Jan 24
Acquisition of C2i Genomics to Add Minimal Residual Disease Capabilities to Its Novel Diagnostics Platform
8:12am
8-K
y9c8q3mv2t 7w
7 Nov 23
Veracyte Announces Third Quarter 2023 Financial Results
4:09pm
8-K
ffpy3 5yolfrbea2zn
8 Aug 23
Veracyte Announces Second Quarter 2023 Financial Results
4:11pm
8-K
m6u 2hktcy5nlnyokwav
9 Jun 23
Departure of Directors or Certain Officers
5:01pm